Sanford C. Bernstein set a GBX 8,100 ($105.84) price objective on Reckitt Benckiser Group (LON:RB) in a report released on Wednesday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
A number of other equities research analysts have also weighed in on RB. Liberum Capital restated a buy rating on shares of Reckitt Benckiser Group in a research report on Tuesday, July 30th. Shore Capital restated an under review rating on shares of Reckitt Benckiser Group in a research report on Tuesday, July 30th. Barclays restated an overweight rating on shares of Reckitt Benckiser Group in a research report on Tuesday, September 3rd. Societe Generale set a GBX 5,700 ($74.48) price objective on Reckitt Benckiser Group and gave the stock a sell rating in a research report on Thursday, August 1st. Finally, UBS Group set a GBX 6,500 ($84.93) price objective on Reckitt Benckiser Group and gave the stock a neutral rating in a research report on Wednesday, September 11th. Four equities research analysts have rated the stock with a sell rating, three have issued a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of GBX 7,112.94 ($92.94).
Shares of RB stock opened at GBX 6,261 ($81.81) on Wednesday. The firm has a market capitalization of $44.39 billion and a P/E ratio of 31.43. Reckitt Benckiser Group has a twelve month low of GBX 5,559 ($72.64) and a twelve month high of GBX 7,174 ($93.74). The company has a quick ratio of 0.43, a current ratio of 0.59 and a debt-to-equity ratio of 85.08. The stock’s fifty day simple moving average is GBX 6,234.86 and its 200 day simple moving average is GBX 6,260.86.
In other Reckitt Benckiser Group news, insider Adrian Nevil Hennah sold 81,063 shares of Reckitt Benckiser Group stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of GBX 6,399 ($83.61), for a total transaction of £5,187,221.37 ($6,778,023.48).
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: Purposes and Functions of the Federal Reserve
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.